Litigation

Recent Posts

S.C. Supreme Court Oks Risperdal Unfair Trade Verdict, Lowers Penalty To $136 Million
Posted on 26 Feb 2015 by Tom Moylan

COLUMBIA, S.C. — (Mealey’s) In a 4-1 ruling, the South Carolina Supreme Court on Feb. 25 affirmed that Janssen Global Services LLC engaged in unfair trade practices through its marketing of the atypical antipsychotic drug Risperdal but shortened... Read More

Tags: drugs , Risperdal , atypical antipsychotic drug , unfair trade practices , South Carolina Unfair Trade Practices Act , product liability , State of South Carolina v. Ortho-McNeil-Janssen Pharmaceuticals , South Carolina , Litigation , Janssen Global Services LLC , Ortho-McNeil-Janssen Pharmaceuticals , torts

Pennsylvania State Court Jury Awards $2.5 Million In Risperdal Gynecomastia Trial
Posted on 24 Feb 2015 by Tom Moylan

PHILADELPHIA — (Mealey’s) A Pennsylvania state court jury on Feb. 24 awarded $2.5 million to the family of a man who claimed that the atypical antipsychotic drug Risperdal caused gynecomastia, or enlarged male breasts ( P.P., et al. v. Ortho... Read More

Tags: drugs , punitive damages , gynecomastia , Risperdal , atypical antipsychotic drug , Austin Pledger , Benita Pledger , et al. v. Ortho-McNeil-Janssen Pharmaceuticals , product liability , P.P. , Pennsylvania , Litigation , Inc. , Ortho-McNeil-Janssen Pharmaceuticals , enlarged male breasts , verdict , torts , Johnson & Johnson , Janssen Pharmaceuticals